AJP - Heart AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (January 19, 2007). doi:10.1152/ajpheart.01197.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/5/H2425    most recent
01197.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmidt-Lucke, C.
Right arrow Articles by Zeiher, A. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt-Lucke, C.
Right arrow Articles by Zeiher, A. M
Submitted on November 1, 2006
Accepted on January 9, 2007

Specific recruitment of CD4+CD25++ regulatory T cells into the allograft in heart transplant recipients

Caroline Schmidt-Lucke1*, Alexandra Aicher1, Paola Romagnani2, Björn Gareis1, Sergio Romagnani2, Stefanie Dimmeler1, and Andreas M Zeiher1

1 Molecular Cardiology, Frankfurt University, Frankfurt, Germany
2 University of Florence, Florence, Italy

* To whom correspondence should be addressed. E-mail: caroline.schmidt-lucke{at}charite.de.

Regulatory T cells migrate into allografts and induce tolerance of the graft. Immunosuppressive regulatory T cells (Treg) are found among CD4+CD25++ T cells and specifically express the forkhead/winged transcription factor FOXP3. We hypothesised that activated T cells (TC) and Treg might modulate the ongoing inflammation of the cardiac allograft (CA) and that the chronic inflammatory environment might influence the balance between these distinct cell types. We therefore quantified levels of activated TC and CD4+CD25++Treg, in the cardiac and systemic circulation in heart transplant recipients. To determine the influence of the allograft passage on these cells, transcardiac gradients were evaluated in CA recipients (n=22) compared to controls (n=18). Systemic levels of circulating Treg were significantly lower in CA recipients (8.9±1.3/ul) compared to controls (15.8±1.6/µl; p=0.002). Similarly, the proportion of Treg related to the total leukocyte number was significantly lower in CA recipients (p<0.01). In contrast, systemic levels of circulating activated CD4+ TC and of circulating plasmacytoid dendritic cells were similar in both groups. In transplant patients, numbers of Treg significantly decreased during transcardiac passage (3.0±0.3 to 2.4±0.3 % of CD4+ T cells, p<0.01), and FOXP3+ TC invaded into the allograft. In contrast, numbers of activated CD4+ TC increased during passage through the allograft even in the presence of effective immunosuppression. In conclusion, numbers of circulating immunosuppressive Treg are reduced in transplant recipients. Recruitment of Treg into the cardiac allograft during transcoronary passage may induce graft tolerance during subclinical inflammation potentially influencing allograft vasculopathy.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.